Factors responsible for stage III disease in patients with Wilms tumor enrolled in the JWiTS-2 study

Japanese multi-center study of 45 stage III Wilms tumor patients found excellent outcomes (95% survival) with current protocols, but high tumor spillage rates (56%) suggest preoperative chemotherapy may be preferable to primary resection in large tumors to reduce treatment intensity and late effects.